Lactobacillus salivarius AP-32

OTHER2 trials

Sponsors

China Medical University Hospital, Hsieh-Hsun Ho

Conditions

Hyperbilirubinemia, NeonatalSafety Issues

Unknown Phase

The Efficacy of Oral Probiotics on Neonatal Hyperbilirubinemia

China Medical University HospitalHyperbilirubinemia, Neonatal

Start: 2019-05-24End: 2023-12-31Target: 180Updated: 2023-07-19

Safety Evaluation of Lactobacillus Salivarius AP-32 and Bifidobacterium Animalis Subsp. Lactis CP-9 in Healthy Infants.

CompletedNCT04140604

Hsieh-Hsun HoSafety Issues

Start: 2020-02-11End: 2022-08-31Updated: 2023-07-19